Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RDUS -https://content.seleritycorp.com/hosted/assets/www/-tOLvdB1_n5lhH1JbeMDaN2KbaCU1MFD7YKqwoJxHps
Radius delivers strong year-end balance sheet with $160M cash2 balance and expects to achieve profitability while investing in its existing pipeline as part of its three-year business objectives
FTC to Examine Past Acquisitions by Large Technology Companies
Agency Issues 6(b) Orders to Alphabet Inc., Amazon.com, Inc., Apple Inc., Facebook, Inc., Google Inc., and Microsoft Corp.
https://www.ftc.gov/news-events/press-releases/2020/02/ftc-examine-past-acquisitions-large-technology-companies
Looks to me like LJPC is positioning itself for $11 pps
Just bought March 20 $18 SPXU calls...I think the market is topping here at least for this week and needs a breather...preferably a new Coronavirus scare LOL
Wow SPRINT! Only took 9 years LOL
I think market the continues to climb after Trump acquittal and Coronavirus news continue to stabilize. Will hold my $12 SPXS $19 SPXU puts longer.
La Jolla Pharmaceutical Company, Inst Holders, 4Q 2019 (LJPC)
3:19 AM ET 1/21/20 | Dow Jones
Related Quotes
11:20 AM ET 2/4/20
Symbol Last % Chg
LJPC
8.00 16.11%
Real time quote.
The following table shows the largest shareholders in LA JOLLA PHARMACEUTICAL CO COM (LJPC) for the quarter ended December 31, 2019, listed by holding size. The list represents up to 50 of the largest holders in the company.
Note: Unless otherwise mentioned the reporting date is 12/31/2019
Institution Shares Shares % Last
Held Changed Held Report
Fidelity Management & Research 4,064,787 0 14.968 09/30
RTW Investments LP 2,016,269 4,929 7.424 09/30
VHCP Management LLC 1,770,000 0 6.518 09/30
Baker Bros. Advisors LP 1,559,231 0 5.742 09/30
BlackRock Fund Advisors 1,324,861 32,282 4.879 09/30
Sectoral Asset Management Inc 1,158,271 (498,900) 4.265 09/30
The Vanguard Group Inc. 986,704 (16,511) 3.633 09/30
Morgan Stanley & Co. LLC 822,332 431,275 3.028 09/30
Tavistock Life Sciences Co. (I 775,000 200,000 2.854 09/30
SSgA Funds Management Inc. 427,553 11,890 1.574 09/30
Rock Springs Capital Managemen 425,000 0 1.565 09/30
PGIM Securities Investment Tru 424,499 0 1.563 09/30
SG Americas Securities LLC 375,986 299,995 1.384 09/30
Geode Capital Management LLC 341,680 25,259 1.258 09/30
Millennium Management LLC 327,057 (725,831) 1.204 09/30
Candriam Belgium SA 326,300 0 1.202 09/30
Northern Trust Investments In 299,889 23,735 1.104 09/30
Assenagon Asset Management SA 284,984 284,984 1.049 12/31
D. E. Shaw & Co. LP 263,869 112,429 0.972 09/30
Broadfin Capital LLC 181,844 (709,916) 0.670 09/30
Spark Investment Management LL 143,600 (86,764) 0.529 09/30
Charles Schwab Investment Mana 129,365 2,667 0.476 12/31
JPMorgan Investment Management 110,475 4,450 0.407 09/30
Employees Retirement System of 86,890 2,890 0.320 09/30
Invesco Capital Management LLC 85,021 85,021 0.313 09/30
AllianceBernstein LP 79,400 (3,400) 0.292 09/30
BlackRock Investment Managemen 75,254 3,911 0.277 09/30
Highland Capital Management LP 68,700 0 0.253 06/30
OxFORD Asset Management LLP 67,682 21,880 0.249 09/30
The Bank of New York Mellon Co 67,008 3,169 0.247 09/30
PDT Partners LLC 59,542 59,542 0.219 09/30
Worth Venture Partners LLC 49,300 27,300 0.182 09/30
Highland Capital Management Fu 49,000 49,000 0.180 09/30
A.R.T. Advisors LLC 48,341 48,341 0.178 09/30
Teachers Advisors LLC 46,776 0 0.172 09/30
Vanguard Fiduciary Trust Co. 42,077 0 0.155 09/30
TIAA-CREF Investment Managemen 36,977 (4,833) 0.136 09/30
BlackRock Advisors LLC 35,330 2,441 0.130 09/30
The California Public Employee 31,900 0 0.117 09/30
California State Teachers' Ret 31,889 0 0.117 09/30
Citadel Advisors LLC 29,393 14,893 0.108 09/30
State of Wisconsin Investment 29,100 0 0.107 09/30
Morgan Stanley Smith Barney LL 27,866 (1,839) 0.103 09/30
Trellus Management Co. LLC 26,845 15,024 0.099 09/30
RhumbLine Advisers LP 26,769 (185) 0.099 09/30
Virtus ETF Advisers LLC 26,021 (1,449) 0.096 09/30
Susquehanna Financial Group LL 23,885 23,885 0.088 09/30
New York State Common Retireme 22,000 10,500 0.081 09/30
ExodusPoint Capital Management 19,619 7,302 0.072 09/30
HighPoint Advisor Group LLC 19,080 514 0.070 09/30
13F data provided by: Factset Research Systems Inc.;
Please send questions to ownership@factset.com.
Copyright, Factset Research Systems, 2020. All Rights Reserved.
> Dow Jones Newswires
January 21, 2020 03:19 ET (08:19 GMT)
La Jolla Pharmaceutical Company, Inst Holders, 4Q 2019 (LJPC)
3:19 AM ET 1/21/20 | Dow Jones
Related Quotes
11:20 AM ET 2/4/20
Symbol Last % Chg
LJPC
8.00 16.11%
Real time quote.
The following table shows the largest shareholders in LA JOLLA PHARMACEUTICAL CO COM (LJPC) for the quarter ended December 31, 2019, listed by holding size. The list represents up to 50 of the largest holders in the company.
Note: Unless otherwise mentioned the reporting date is 12/31/2019
Institution Shares Shares % Last
Held Changed Held Report
Fidelity Management & Research 4,064,787 0 14.968 09/30
RTW Investments LP 2,016,269 4,929 7.424 09/30
VHCP Management LLC 1,770,000 0 6.518 09/30
Baker Bros. Advisors LP 1,559,231 0 5.742 09/30
BlackRock Fund Advisors 1,324,861 32,282 4.879 09/30
Sectoral Asset Management Inc 1,158,271 (498,900) 4.265 09/30
The Vanguard Group Inc. 986,704 (16,511) 3.633 09/30
Morgan Stanley & Co. LLC 822,332 431,275 3.028 09/30
Tavistock Life Sciences Co. (I 775,000 200,000 2.854 09/30
SSgA Funds Management Inc. 427,553 11,890 1.574 09/30
Rock Springs Capital Managemen 425,000 0 1.565 09/30
PGIM Securities Investment Tru 424,499 0 1.563 09/30
SG Americas Securities LLC 375,986 299,995 1.384 09/30
Geode Capital Management LLC 341,680 25,259 1.258 09/30
Millennium Management LLC 327,057 (725,831) 1.204 09/30
Candriam Belgium SA 326,300 0 1.202 09/30
Northern Trust Investments In 299,889 23,735 1.104 09/30
Assenagon Asset Management SA 284,984 284,984 1.049 12/31
D. E. Shaw & Co. LP 263,869 112,429 0.972 09/30
Broadfin Capital LLC 181,844 (709,916) 0.670 09/30
Spark Investment Management LL 143,600 (86,764) 0.529 09/30
Charles Schwab Investment Mana 129,365 2,667 0.476 12/31
JPMorgan Investment Management 110,475 4,450 0.407 09/30
Employees Retirement System of 86,890 2,890 0.320 09/30
Invesco Capital Management LLC 85,021 85,021 0.313 09/30
AllianceBernstein LP 79,400 (3,400) 0.292 09/30
BlackRock Investment Managemen 75,254 3,911 0.277 09/30
Highland Capital Management LP 68,700 0 0.253 06/30
OxFORD Asset Management LLP 67,682 21,880 0.249 09/30
The Bank of New York Mellon Co 67,008 3,169 0.247 09/30
PDT Partners LLC 59,542 59,542 0.219 09/30
Worth Venture Partners LLC 49,300 27,300 0.182 09/30
Highland Capital Management Fu 49,000 49,000 0.180 09/30
A.R.T. Advisors LLC 48,341 48,341 0.178 09/30
Teachers Advisors LLC 46,776 0 0.172 09/30
Vanguard Fiduciary Trust Co. 42,077 0 0.155 09/30
TIAA-CREF Investment Managemen 36,977 (4,833) 0.136 09/30
BlackRock Advisors LLC 35,330 2,441 0.130 09/30
The California Public Employee 31,900 0 0.117 09/30
California State Teachers' Ret 31,889 0 0.117 09/30
Citadel Advisors LLC 29,393 14,893 0.108 09/30
State of Wisconsin Investment 29,100 0 0.107 09/30
Morgan Stanley Smith Barney LL 27,866 (1,839) 0.103 09/30
Trellus Management Co. LLC 26,845 15,024 0.099 09/30
RhumbLine Advisers LP 26,769 (185) 0.099 09/30
Virtus ETF Advisers LLC 26,021 (1,449) 0.096 09/30
Susquehanna Financial Group LL 23,885 23,885 0.088 09/30
New York State Common Retireme 22,000 10,500 0.081 09/30
ExodusPoint Capital Management 19,619 7,302 0.072 09/30
HighPoint Advisor Group LLC 19,080 514 0.070 09/30
13F data provided by: Factset Research Systems Inc.;
Please send questions to ownership@factset.com.
Copyright, Factset Research Systems, 2020. All Rights Reserved.
> Dow Jones Newswires
January 21, 2020 03:19 ET (08:19 GMT)
LJPC Mar 20 '20 $4 Call LA JOLLA PHARMACEUTICAL CO
still holding one for earnings on Feb 4
Two Small Biotechs See Big Stock Purchases by Their Largest Holders -- Barrons.com
6:59 AM ET 1/15/20 | Dow Jones
Quote:
On Monday, investment firm Tang Capital Management disclosed that it had paid $17.4 million from Jan. 9-13 for 2.97 million additional shares of La Jolla, an average per-share price of $5.87, according to a form it filed with the Securities and Exchange Commission. It now owns 7.9 million La Jolla shares. Tang Capital's president, Kevin Tang, is also chairman of La Jolla. Including the 310,000 La Jolla shares that Kevin Tang personally owns, his 8.2 million shares represent a 30.2% stake in La Jolla.
These purchases of La Jolla stock are Tang Capital's first since last January, when it paid $7 million for 1.2 million shares, an average per-share price of $5.37 each.
La Jolla Pharm reports prelim Q4 GIAPREZA net sales were $7.2 million, up 71% from the three months ended December 31, 2018
8:01 AM ET 1/9/20 | Briefing.com
Quote:
Vials of GIAPREZA shipped from distributors to hospitals (hospital demand) grew 74% for the three months ended December 31, 2019 as compared to the three months ended December 31, 2018 and 18% as compared to the three months ended September 30, 2019. For the twelve months ended December 31, 2019, preliminary GIAPREZA net sales were $23.1 million, up 129% from the twelve months ended December 31, 2018. La Jolla announced the commercial availability of GIAPREZA in the U.S. in March 2018.
LJPC took another 16% leap up...earnings today
SPXS SPXU puts are rockin today!!!
LJPC Mar 20 '20 $4 Call LA JOLLA PHARMACEUTICAL CO
still holding one for earnings on Feb 4
Two Small Biotechs See Big Stock Purchases by Their Largest Holders -- Barrons.com
6:59 AM ET 1/15/20 | Dow Jones
LJPC Mar 20 '20 $4 Call LA JOLLA PHARMACEUTICAL CO
still holding one for earnings on Feb 4
Two Small Biotechs See Big Stock Purchases by Their Largest Holders -- Barrons.com
6:59 AM ET 1/15/20 | Dow Jones
Good afternoon! Hope everyone bet against the SPX like I did
Don't wish death on anyone but I think in this day and age it'll take someone famous that contracts and dies from the coronavirus to get this market to "correct" itself
DIREXION SHARES ETF TRUST DIREXION DAILY S&P 500 BEAR 3X SHARES
FEB-20 $13.00 CALL
January 30, 2020 10:46 AM ET
(SPXS Feb 21 '20 $13 Call) 0.64 + 0.19 (+42.22%)
made the right call with SPXS calls
132 deaths 6000 infected
I'm buying Feb and March SPXS and SPXU calls
thanks LOL but I guess the corona virus wasn't cooked in all the way this past week's dip and it continues to get killed even on a beat...what a dog!
clearly not...I was hoping the corona virus would have already been baked in and I could have got a little bounce for my calls but oh well...
01/28/20 15:41PM EST
Buy 10 SBUX Jan 31 '20 $95 Call Executed @ $0.25
fuck it, just in for the bounce then I'm out
UPDATE: 5 reasons coronavirus fears are overblown -- and 14 stocks to buy now
6:13 AM ET 1/28/20 | MarketWatch
By Michael Brush, MarketWatch
'We don't expect these factors supporting investor confidence and consumer spending to change anytime soon'
Investor fears about the coronavirus are overblown.
So Monday's biggest one-day percentage declines since early October in the Dow Jones Industrial Average and the S&P 500 index on coronavirus fears have created nice buying opportunities in 14 stocks with lots of exposure to China.
Before we get to those, here are five reasons why investors are panicking too much about coronavirus.
1. Past contagious disease breakouts have been contained
The big unknown here is how deadly and contagious coronavirus is. No one really knows, but medical experts at Johns Hopkins are downplaying the threat from 2019-nCoV, the name for the type of coronavirus grabbing headlines.
"The immediate health risk from 2019-nCoV to the general public in the United States is thought to be low at this time," says Gabor Kelen, a medical doctor and director of the Johns Hopkins Office of Critical Event Preparedness and Response.
Even if coronavirus turns out to be as contagious and deadly as really bad contagious diseases like Ebola, it will most likely be successfully curbed. The Ebola outbreak a few years ago was effectively kept in check, and so were the Severe Acute Respiratory Syndrome (SARS) outbreak of 2003-04, and the Middle East Respiratory Syndrome (MERS) outbreak early last decade.
"All three outbreaks were contained before they could have a significant impact on the global economy or financial markets around the world," says Ed Yardeni, of Yardeni Research. "We expect the same outcome with the current outbreak."
The good news is that health officials learned a lot about containing virus outbreaks from those three experiences.
"Health technology has advanced considerably," says Andrew Tilton, the chief Asia economist at Goldman Sachs. "Chinese authorities have already sequenced the virus and shared it with the global health community, and the U.S. Centers for Disease Control have just developed a test for the virus."
Another positive is that public awareness seems to be much higher, because of the more rapid of cial response in China and the internet and social media, says Tilton. Local authorities in China reported SARS quickly in early January 2003. But up the chain of command, officials dragged their feet. The rst official press conference on SARS did not happen until Feb. 11.
Read:CDC officials say coronavirus is similar to SARS, no new U.S. cases reported (http://www.marketwatch.com/story/cdc-officials-say-coronavirus-is-similar-to-sars-no-new-us-cases-reported-2020-01-27)
2. The lockdown affects a small part of China
But what about the lockdown? Even if coronavirus is contained, won't the lockdown have a big impact on China's economy? Probably not, at least as things stand now. The cities locked down are all near Wuhan (http://www.marketwatch.com/story/mayor-of-wuhan-epicenter-of-coronavirus-outbreak-says-5-million-people-left-the-city-before-travel-restrictions-were-imposed-2020-01-26), in Hubei province, where coronavirus originated. So far, the lockdown affects only around 60 million people out of a population of 1.4 billion.
Likewise, Hubei province only produces about 4.7% of China's overall GDP, according to the National Bureau of Statistics of China.
Read:3 reasons coronavirus won't derail China's economy (http://www.marketwatch.com/story/three-reasons-coronavirus-wont-derail-chinas-economy-2020-01-27)
3. The breakout happened at an opportune time
China's economy was about to wind down anyway for the Chinese New Year celebration when the outbreak occured. So productivity was already scheduled to take a seasonal dip.
To the extent that the virus in China creates domestic fear and unrest, or hurts the economy, it weakens China's Premier Xi Jinping's hand in tariff negotiations with the U.S. This suggests and easier path toward progress, which would be a positive for business confidence and the U.S. stock market.
Of course, the bad news here is that a lot more people in China have travel plans around the New Year. This could make the virus spread more quickly.
4. The public typically tends to overreact to health threats
Whenever there's a new virus outbreak, people are egged on by the media echo chamber, which latches on to the story and repeats it ad nauseum, drilling fear and concern into the minds of investors and the general public alike. The same thing happens on social media, where rumors can spread unchecked.
This amplifies the perception of risk, but not the risk itself. At some point and perhaps soon, the media and Twitter will move on to the next story of the day, and coronavirus fears will ease.
The echo chamber impact was compounded by the following problem: Investor sentiment was extremely high going into this (both the Dow and the S&P set the latest in a string of records on Jan. 17), which made the market more vulnerable to "bad news" and negative headlines. Overconfident investors are convinced that nothing can go wrong. So when something negative crops up, they're surprised and they feel betrayed, which escalates their selling.
Part of the exaggerated reaction to coronavirus is linked to the fact that it is new, and emanating from a foreign country. The fears about it seem irrational, if you consider the following contrasts. So far, coronavirus has claimed fewer than 100 lives. SARS, which also sparked widespread panic and investor selling, claimed hundreds of lives, and fewer than 10,000 cases were reported.
In contrast, other flu viruses in circulation in the U.S. last year took over 34,000 lives, and they are taking a similar toll this year. Yet unlike coronavirus and SARS, these flu viruses have had zero impact on the stock market. This suggests the current hysteria developing about coronavirus is irrational.
Read:As fifth coronavirus case is confirmed in the U.S. -- this is how the illness has spread across the world so rapidly (http://www.marketwatch.com/story/how-the-mysterious-coronavirus-from-china-has-spread-so-quickly-2020-01-21)
5. Any economic impact will be short lived
Coronavirus fears could hit travel globally, and produce a decline in consumer spending in Asia and the U.S. But the effect tends to wear off pretty fast. "These retrenchments in spending are short-lived as consumers eventually get frugal fatigue," says Jay Bryson, acting chief economist at Wells Fargo Securities.
One fear is that there could be enough of a pullback in consumer spending and travel to hit economic growth. But again, the effect will probably be limited. "The negative impact on growth and asset prices from viral outbreaks typically normalizes within a few months," says Tilton at Goldman Sachs.
"The outbreak of the coronavirus could drive large swings in Mainland China and emerging Asia growth in the first half but a much smaller impact on full-year growth, if the SARS episode is any guide," says JP Morgan economist Bruce Kasman.
Several recent developments will continue support the economy and the stock market, says Baird chief investment strategist Bruce Bittles. He cites recent progress on U.S.-China trade talks, an accommodative Federal Reserve, low interest rates, and muted inflation. "We don't expect these factors supporting investor confidence and consumer spending to change anytime soon," he says.
Read:Economic hit from coronavirus likely to be short lived, but it's still 'a little scary, frankly' (http://www.marketwatch.com/story/economic-hit-from-coronavirus-likely-to-be-short-lived-but-its-still-a-little-scary-frankly-2020-01-27)
What stocks to buy
All of this suggest stocks hit particularly hard because they have exposure to China look like buys here.
Take Royal Caribbean Cruises(RCL), for example.
"If history is any guide, the weakness in Royal's stock could present a compelling buying opportunity as consumers have been fairly quick to shrug off illness outbreaks in recent years," says William Blair analyst Sharon Zackfia. The cruise industry actually did better after the SARS outbreak and "more recent outbreaks such as Zika or Ebola have had no discernible impact on cruise demand," she says.
Also consider U.S. companies getting hit hard in the past few days because of China exposure. They include: Starbucks (SBUX), Walt Disney (DIS), Nike (NKE), Estée Lauder (EL), Wynn Resorts (WYNN), Las Vegas Sands (LVS), Marriott International (MAR), Hyatt Hotels (H), Yum China Holdings (YUMC), IMAX (IMAX), PVH (PVH), Tapestry (TPR), and GreenTree Hospitality Group (GHG)
Read:These U.S. stocks are down the most as the coronavirus spreads (http://www.marketwatch.com/story/these-us-stocks-are-down-the-most-as-the-coronavirus-spreads-2020-01-27)
Of course, if there's a massive coronavirus outbreak in China, all bets are off, but that's not my base case. To track the progress, see this map from Johns Hopkins (https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6).
Now read:Your 6-point plan to navigating a choppy stock market (http://www.marketwatch.com/story/your-6-point-plan-to-navigating-a-choppy-stock-market-2020-01-27)
At the time of publication, Michael Brush had no positions in any stocks mentioned in this column. During the past 10 years, Brush has suggested RCL, SBUX, WYNN, DIS, MAR and H in his stock newsletter Brush Up on Stocks (http://www.uponstocks.com/).
-Michael Brush; 415-439-6400; AskNewswires@dowjones.com
> Dow Jones Newswires
January 28, 2020 06:13 ET (11:13 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
DIREXION SHARES ETF TRUST DIREXION DAILY FINANCIAL BEAR 3X SHARES MAR-20 $24.00 PUT
(FAZ Mar 20 '20 $24 Put)
for the market's bounce back
UPDATE: 5 reasons coronavirus fears are overblown -- and 14 stocks to buy now
6:13 AM ET 1/28/20 | MarketWatch
By Michael Brush, MarketWatch
'We don't expect these factors supporting investor confidence and consumer spending to change anytime soon'
Investor fears about the coronavirus are overblown.
So Monday's biggest one-day percentage declines since early October in the Dow Jones Industrial Average and the S&P 500 index on coronavirus fears have created nice buying opportunities in 14 stocks with lots of exposure to China.
Before we get to those, here are five reasons why investors are panicking too much about coronavirus.
1. Past contagious disease breakouts have been contained
The big unknown here is how deadly and contagious coronavirus is. No one really knows, but medical experts at Johns Hopkins are downplaying the threat from 2019-nCoV, the name for the type of coronavirus grabbing headlines.
"The immediate health risk from 2019-nCoV to the general public in the United States is thought to be low at this time," says Gabor Kelen, a medical doctor and director of the Johns Hopkins Office of Critical Event Preparedness and Response.
Even if coronavirus turns out to be as contagious and deadly as really bad contagious diseases like Ebola, it will most likely be successfully curbed. The Ebola outbreak a few years ago was effectively kept in check, and so were the Severe Acute Respiratory Syndrome (SARS) outbreak of 2003-04, and the Middle East Respiratory Syndrome (MERS) outbreak early last decade.
"All three outbreaks were contained before they could have a significant impact on the global economy or financial markets around the world," says Ed Yardeni, of Yardeni Research. "We expect the same outcome with the current outbreak."
The good news is that health officials learned a lot about containing virus outbreaks from those three experiences.
"Health technology has advanced considerably," says Andrew Tilton, the chief Asia economist at Goldman Sachs. "Chinese authorities have already sequenced the virus and shared it with the global health community, and the U.S. Centers for Disease Control have just developed a test for the virus."
Another positive is that public awareness seems to be much higher, because of the more rapid of cial response in China and the internet and social media, says Tilton. Local authorities in China reported SARS quickly in early January 2003. But up the chain of command, officials dragged their feet. The rst official press conference on SARS did not happen until Feb. 11.
Read:CDC officials say coronavirus is similar to SARS, no new U.S. cases reported (http://www.marketwatch.com/story/cdc-officials-say-coronavirus-is-similar-to-sars-no-new-us-cases-reported-2020-01-27)
2. The lockdown affects a small part of China
But what about the lockdown? Even if coronavirus is contained, won't the lockdown have a big impact on China's economy? Probably not, at least as things stand now. The cities locked down are all near Wuhan (http://www.marketwatch.com/story/mayor-of-wuhan-epicenter-of-coronavirus-outbreak-says-5-million-people-left-the-city-before-travel-restrictions-were-imposed-2020-01-26), in Hubei province, where coronavirus originated. So far, the lockdown affects only around 60 million people out of a population of 1.4 billion.
Likewise, Hubei province only produces about 4.7% of China's overall GDP, according to the National Bureau of Statistics of China.
Read:3 reasons coronavirus won't derail China's economy (http://www.marketwatch.com/story/three-reasons-coronavirus-wont-derail-chinas-economy-2020-01-27)
3. The breakout happened at an opportune time
China's economy was about to wind down anyway for the Chinese New Year celebration when the outbreak occured. So productivity was already scheduled to take a seasonal dip.
To the extent that the virus in China creates domestic fear and unrest, or hurts the economy, it weakens China's Premier Xi Jinping's hand in tariff negotiations with the U.S. This suggests and easier path toward progress, which would be a positive for business confidence and the U.S. stock market.
Of course, the bad news here is that a lot more people in China have travel plans around the New Year. This could make the virus spread more quickly.
4. The public typically tends to overreact to health threats
Whenever there's a new virus outbreak, people are egged on by the media echo chamber, which latches on to the story and repeats it ad nauseum, drilling fear and concern into the minds of investors and the general public alike. The same thing happens on social media, where rumors can spread unchecked.
This amplifies the perception of risk, but not the risk itself. At some point and perhaps soon, the media and Twitter will move on to the next story of the day, and coronavirus fears will ease.
The echo chamber impact was compounded by the following problem: Investor sentiment was extremely high going into this (both the Dow and the S&P set the latest in a string of records on Jan. 17), which made the market more vulnerable to "bad news" and negative headlines. Overconfident investors are convinced that nothing can go wrong. So when something negative crops up, they're surprised and they feel betrayed, which escalates their selling.
Part of the exaggerated reaction to coronavirus is linked to the fact that it is new, and emanating from a foreign country. The fears about it seem irrational, if you consider the following contrasts. So far, coronavirus has claimed fewer than 100 lives. SARS, which also sparked widespread panic and investor selling, claimed hundreds of lives, and fewer than 10,000 cases were reported.
In contrast, other flu viruses in circulation in the U.S. last year took over 34,000 lives, and they are taking a similar toll this year. Yet unlike coronavirus and SARS, these flu viruses have had zero impact on the stock market. This suggests the current hysteria developing about coronavirus is irrational.
Read:As fifth coronavirus case is confirmed in the U.S. -- this is how the illness has spread across the world so rapidly (http://www.marketwatch.com/story/how-the-mysterious-coronavirus-from-china-has-spread-so-quickly-2020-01-21)
5. Any economic impact will be short lived
Coronavirus fears could hit travel globally, and produce a decline in consumer spending in Asia and the U.S. But the effect tends to wear off pretty fast. "These retrenchments in spending are short-lived as consumers eventually get frugal fatigue," says Jay Bryson, acting chief economist at Wells Fargo Securities.
One fear is that there could be enough of a pullback in consumer spending and travel to hit economic growth. But again, the effect will probably be limited. "The negative impact on growth and asset prices from viral outbreaks typically normalizes within a few months," says Tilton at Goldman Sachs.
"The outbreak of the coronavirus could drive large swings in Mainland China and emerging Asia growth in the first half but a much smaller impact on full-year growth, if the SARS episode is any guide," says JP Morgan economist Bruce Kasman.
Several recent developments will continue support the economy and the stock market, says Baird chief investment strategist Bruce Bittles. He cites recent progress on U.S.-China trade talks, an accommodative Federal Reserve, low interest rates, and muted inflation. "We don't expect these factors supporting investor confidence and consumer spending to change anytime soon," he says.
Read:Economic hit from coronavirus likely to be short lived, but it's still 'a little scary, frankly' (http://www.marketwatch.com/story/economic-hit-from-coronavirus-likely-to-be-short-lived-but-its-still-a-little-scary-frankly-2020-01-27)
What stocks to buy
All of this suggest stocks hit particularly hard because they have exposure to China look like buys here.
Take Royal Caribbean Cruises(RCL), for example.
"If history is any guide, the weakness in Royal's stock could present a compelling buying opportunity as consumers have been fairly quick to shrug off illness outbreaks in recent years," says William Blair analyst Sharon Zackfia. The cruise industry actually did better after the SARS outbreak and "more recent outbreaks such as Zika or Ebola have had no discernible impact on cruise demand," she says.
Also consider U.S. companies getting hit hard in the past few days because of China exposure. They include: Starbucks (SBUX), Walt Disney (DIS), Nike (NKE), Estée Lauder (EL), Wynn Resorts (WYNN), Las Vegas Sands (LVS), Marriott International (MAR), Hyatt Hotels (H), Yum China Holdings (YUMC), IMAX (IMAX), PVH (PVH), Tapestry (TPR), and GreenTree Hospitality Group (GHG)
Read:These U.S. stocks are down the most as the coronavirus spreads (http://www.marketwatch.com/story/these-us-stocks-are-down-the-most-as-the-coronavirus-spreads-2020-01-27)
Of course, if there's a massive coronavirus outbreak in China, all bets are off, but that's not my base case. To track the progress, see this map from Johns Hopkins (https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6).
Now read:Your 6-point plan to navigating a choppy stock market (http://www.marketwatch.com/story/your-6-point-plan-to-navigating-a-choppy-stock-market-2020-01-27)
At the time of publication, Michael Brush had no positions in any stocks mentioned in this column. During the past 10 years, Brush has suggested RCL, SBUX, WYNN, DIS, MAR and H in his stock newsletter Brush Up on Stocks (http://www.uponstocks.com/).
-Michael Brush; 415-439-6400; AskNewswires@dowjones.com
> Dow Jones Newswires
January 28, 2020 06:13 ET (11:13 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
oops...thought I saw TSLA in your post...need coffee LOL
I bought a few $6.00 puts yesterday right after I posted it here. What goes up must come down LOL
Yes!!!!!!!!! Novavax Stock Falls After Jumping On Virus Concerns -- MarketWatch
8:46 AM ET 1/22/20 | MarketWatch
Shares of Novavax Inc. (NVAX) tumbled 15% in premarket trading on Wednesday following a day in which growing concern about the new coronavirus sent shares of vaccine developers soaring (http://www.marketwatch.com/story/experimental-vaccine-stocks-jump-on-concerns-about-new-virus-in-china-2020-01-21). On Tuesday after the market closed, Novavax filed an S-1 seeking to sell more than $100 million of its stock. The clinical-stage biotechnology company, which is developing a flu vaccine, told analysts it is developing clones from the new coronavirus as part of the first steps in developing a vaccine to treat the newly identified virus. "We don't expect Novavax will run human trials without non-dilutive government funding," Ladenburg Thalmann's Michael Higgens wrote in a note. "The timing for such support in our view depends on how severe and uncontrolled the 2019-nCoV becomes." Novavax in 2013 had developed a vaccine for Middle East respiratory syndrome (MERS), which is also a coronavirus. This coronavirus was first identified in Wuhan City, China, and has infected more than 300 people and killed at least six more. The Centers for Disease Control and Prevention said Tuesday that a U.S. resident who had traveled to Wuhan and is now in Washington state is currently being treated. He is the first U.S. resident to be diagnosed with the virus. Novavax's stock has fallen 75% over the last year, while the SPDR S&P Biotech (XBI) exchange-traded fund has climbed 13%.
-Jaimy Lee
For more from MarketWatch: http://www.marketwatch.com/newsviewer
> Dow Jones Newswires
January 22, 2020 08:46 ET (13:46 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
China virus scare and a dead board? Lakeland Industries Up Over 17%, on Pace for Largest Percent Increase Since November 2014 -- Data Talk
11:53 AM ET 1/21/20 | Dow Jones
Lakeland Industries, Inc. (LAKE) is currently at $12.86, up $1.90 or 17.27%
-- Would be highest close since May 14, 2019, when it closed at $12.91
-- On pace for largest percent increase since Nov. 25, 2014, when it rose 36.65%
-- Currently up five of the past six days
-- Up 19.12% year-to-date
-- Down 55.64% from its all-time closing high of $29.00 on Oct. 13, 2014
-- Up 14.05% from 52 weeks ago (Jan. 22, 2019), when it closed at $11.28
-- Down 0.35% from its 52 week closing high of $12.91 on May 14, 2019
-- Up 28.91% from its 52 week closing low of $9.98 on July 22, 2019
-- Traded as high as $13.25; highest intraday level since Dec. 4, 2018, when it hit $13.62
-- Up 20.78% at today's intraday high; largest intraday percent increase since Nov. 25, 2014, when it rose as much as 37.36%
All data as of 11:48:18 AM
Source: Dow Jones Market Data, FactSet
> Dow Jones Newswires
January 21, 2020 11:53 ET (16:53 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
NVAX China Virus play...
Last Price
$9.16
Today’s Change
+3.42 (+59.58%)
what's the opposite of a dead cat bounce? a hot air balloon?
good afternoon! Lakeland Industries Up Over 17%, on Pace for Largest Percent Increase Since November 2014 -- Data Talk
11:53 AM ET 1/21/20 | Dow Jones
Related Quotes
3:04 PM ET 1/21/20
Symbol LAKE
Last 14.39
% Chg 31.18%
Real time quote.
Lakeland Industries, Inc. (LAKE) is currently at $12.86, up $1.90 or 17.27%
-- Would be highest close since May 14, 2019, when it closed at $12.91
-- On pace for largest percent increase since Nov. 25, 2014, when it rose 36.65%
-- Currently up five of the past six days
-- Up 19.12% year-to-date
-- Down 55.64% from its all-time closing high of $29.00 on Oct. 13, 2014
-- Up 14.05% from 52 weeks ago (Jan. 22, 2019), when it closed at $11.28
-- Down 0.35% from its 52 week closing high of $12.91 on May 14, 2019
-- Up 28.91% from its 52 week closing low of $9.98 on July 22, 2019
-- Traded as high as $13.25; highest intraday level since Dec. 4, 2018, when it hit $13.62
-- Up 20.78% at today's intraday high; largest intraday percent increase since Nov. 25, 2014, when it rose as much as 37.36%
All data as of 11:48:18 AM
Source: Dow Jones Market Data, FactSet
> Dow Jones Newswires
January 21, 2020 11:53 ET (16:53 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
well put!
64 days until my $4 calls expire to find out
Based on the chart and SS I believe you'll have the chance to make those gains again and again. Today was spectacular and I expect a bit of a pullback to reset the chart but honestly I see nothing stopping it until the $11's
meant to say March calls LOL
still going strong...paid $1.00 for my calls which are sitting at $4.40 roight now
200sma destroyed today
chart is bullish!
(LJPC Mar 20 '20 $4 Call)
January 20, 2020 1:15 PM ET
Last Price 4.40 Today's Change + 1.38 (+45.70%)
Price Paid 1.00
Day's Gain 600.00
Total Gain$ 1722.40
Total Gain % 342.71
$LJPC Last Price $8.39 Today’s Change +1.39 (+19.86%)
200sma broken and staying above
$LJPC Last Price $8.39 Today’s Change +1.39 (+19.86%)
$LJPC Last Price $8.39 Today’s Change +1.39 (+19.86%)
$LJPC Last Price $8.39 Today’s Change +1.39 (+19.86%)